RATIONALE-303: Long-Term Outcomes of Tislelizumab in Previously Treated Advanced/Metastatic NSCLC
- DOI
- 10.1016/j.jtocrr.2026.101028
- Published
- 2026-08
- Container
- JTO Clinical and Research Reports
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtocrr.2026.101028,
title = {RATIONALE-303: Long-Term Outcomes of Tislelizumab in Previously Treated Advanced/Metastatic NSCLC},
author = {Pedro de Marchi and Yun Fan and Zhiyong Ma and Yan Wang and Yuanyuan Bao and Wenjuan Zheng and Kirsha Naicker and Caicun Zhou},
year = {2026},
journal = {JTO Clinical and Research Reports},
doi = {10.1016/j.jtocrr.2026.101028},
url = {https://doi.org/10.1016/j.jtocrr.2026.101028}
}RIS
TY - JOUR TI - RATIONALE-303: Long-Term Outcomes of Tislelizumab in Previously Treated Advanced/Metastatic NSCLC AU - Pedro de Marchi AU - Yun Fan AU - Zhiyong Ma AU - Yan Wang AU - Yuanyuan Bao AU - Wenjuan Zheng AU - Kirsha Naicker AU - Caicun Zhou PY - 2026 JO - JTO Clinical and Research Reports DO - 10.1016/j.jtocrr.2026.101028 UR - https://doi.org/10.1016/j.jtocrr.2026.101028 ER -
APA
Marchi, P. D., Fan, Y., Ma, Z., Wang, Y., Bao, Y., Zheng, W., Naicker, K., & Zhou, C. (2026). RATIONALE-303: Long-Term Outcomes of Tislelizumab in Previously Treated Advanced/Metastatic NSCLC. JTO Clinical and Research Reports. https://doi.org/10.1016/j.jtocrr.2026.101028
Source records
- crossref · retrieved 2026-09-25T08:51:32.340Z